Primary outcomes of the enhanced, EHR-facilitated cancer symptom control (E2C2) cluster-randomized, stepped wedge, pragmatic trial.

person Andrea L. Cheville Mayo Clinic Department of Pediatric and Adolescent Medicine, Rochester, MN info_outline Andrea L. Cheville, Deirdre R. Pachman, Kurt Kroenke, Jeph Herrin, Veronica Grzegorczyk, Sandra A. Mitchell, Joan M. Griffin, Jennifer Ridgeway, Jessica Austin, Ashley Wilder Smith, Linda L. Chlan, Cindy Tofthagen, Kathryn Jean Ruddy

Authors person Andrea L. Cheville Mayo Clinic Department of Pediatric and Adolescent Medicine, Rochester, MN info_outline Andrea L. Cheville, Deirdre R. Pachman, Kurt Kroenke, Jeph Herrin, Veronica Grzegorczyk, Sandra A. Mitchell, Joan M. Griffin, Jennifer Ridgeway, Jessica Austin, Ashley Wilder Smith, Linda L. Chlan, Cindy Tofthagen, Kathryn Jean Ruddy Organizations Mayo Clinic Department of Pediatric and Adolescent Medicine, Rochester, MN, Mayo Clinic, Rochester, MN, Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN, Yale University School of Medicine, New Haven, CT, National Cancer Institute, Bethesda, MD, Mayo Clinic, Scottsdale, AZ, Mayo Clinic Florida, Jacksonville, FL Abstract Disclosures

Clinical